SCHEMBL4557713

SCHEMBL4557713

CCS(=O)(=O)O.NC(=O)Nc1cn[nH]c1

nearest known ligand 0.41

Known targets — ChEMBL curated mechanism

FGFR1FGFR2FGFR3FGFR4FLT1FLT4KDRPDGFRAPDGFRB

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.41
PIM3 Q86V86 1/20 0.41
PIM2 Q9P1W9 1/20 0.41
ALDH1A1 P00352 1/20 0.41
KDM1A O60341 1/20 0.40
MAOA P21397 1/20 0.40
HPGDS O60760 1/20 0.39
PIK3CA P42336 3/20 0.38
MTOR P42345 2/20 0.38
NAMPT P43490 6/20 0.36
MAPT P10636 1/20 0.36
HSD17B10 Q99714 1/20 0.36
ROCK1 Q13464 2/20 0.36
MYLK4 Q86YV6 1/20 0.36
NOS2 P35228 1/20 0.36
GLA P06280 1/20 0.34
MAPK7 Q13164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4158764 0.87
Hydrochloric Acid SCHEMBL4564742 0.85 PIM1 (0.49) PIM1PIM3PIM2ALDH1A1KDM1A
SCHEMBL26854534 0.75 POLB (0.47) PIM1PIM3PIM2ALDH1A1KDM1A
Methylamine SCHEMBL27814550 0.73 PIM1 (0.47) PIM1PIM3PIM2ALDH1A1KDM1A
SCHEMBL13373468 0.72 TP53 (0.51) PIM1PIM3PIM2ALDH1A1MAPT
SCHEMBL11358876 0.72
Hydrochloric Acid SCHEMBL20557184 0.71 PIM1 (0.49) PIM1PIM3PIM2ALDH1A1KDM1A
SCHEMBL929848 0.70 PIM1 (0.51) PIM1PIM3PIM2KDM1AMAOA
SCHEMBL13373362 0.70 HSD17B10 (0.51) PIM1PIM3PIM2ALDH1A1HSD17B10
SCHEMBL13373479 0.70 HSD17B10 (0.51) PIM1PIM3PIM2ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049119-A2 PHARMACEUTICAL COMBINATIONS OF 1-CYCLOPROPYL-3-[3-(5-MORPHOOLIN-4-YLMETHYL-1H-BENZOIMIDAZOL-2-YL)-1H-1-PYRAZOL-4-YL]-UREA Astex Therapeutics Limited (GB) 2009-04-22 EP disclosed
WO-2008001115-A2 PHARMACEUTICAL COMBINATIONS OF 1-CYCLOPROPYL-3- [3- (5-M0RPHOOLIN-4-YLMETHYL-1H-BENZOIMIDAZOL-2-YL) -LH-1-PYRAZOL- 4-YL] -UREA ASTEX THERAPEUTICS LIMITED (GB) 2008-01-03 WO disclosed